KPP
BSX icon

Kings Path Partners’s Boston Scientific BSX Stock Holding History

Kings Path Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Hold
706
– – 0.01% 199
2026
Q1 		$67.3K Hold
706
– – 0.02% 155
2025
Q4 		$67.3K Hold
706
– – 0.02% 155
2025
Q3 		$68.9K Hold
706
– – 0.03% 149
2025
Q2 		$75.8K Hold
706
– – 0.03% 137
2025
Q1 		$71.2K Hold
706
– – 0.03% 134
2024
Q4 		$63.1K Hold
706
– – 0.03% 166
2024
Q3 		$59.2K Hold
706
– – 0.02% 171
2024
Q2 		$54.4K Buy
+706
New +$51.7K 0.03% 157

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Kings Path Partners's BSX Position: Q2 2026 in Review

Kings Path Partners held its Boston Scientific (BSX) position steady in Q2 2026 at 706 shares worth $30.1K. The position accounts for 0.01% of the portfolio, ranked #199.

Kings Path Partners first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $75.8K in Q2 2025. 241 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kings Path Partners held 706 shares of Boston Scientific worth $30.1K as of Q2 2026.
  • Kings Path Partners left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.01% of Kings Path Partners's portfolio in Q2 2026, its #199 holding.
  • Kings Path Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Kings Path Partners's Boston Scientific position peaked at $75.8K in Q2 2025.
  • 241 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.